Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases
NCT ID: NCT05930444
Last Updated: 2024-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9825 participants
OBSERVATIONAL
2023-07-21
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research on the Real-World Community Application of Large Language Models
NCT06966882
Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application
NCT03899623
Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection
NCT05231174
Validation of the Utility of Ophthalmology Intelligent Diagnostic System
NCT03499145
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
NCT06755190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal participants
Healthy individuals who have no concerns related to their eyes.
No interventions assigned to this group
Patients with Eye-related Chief Complaints
Individuals who have specific concerns or issues related to their eyes, which they consider as the main reason for seeking medical attention or making a complaint.
Multimodal Machine Learning Program for Auxiliary Diagnosis of Eye Diseases
Patients presenting with eye-related chief complaints initially complete a mobile phone application. This application utilizes patient medical history and relevant images (such as selfies and photos from eye examinations) to provide intelligent diagnosis. The diagnosis remains undisclosed to the patients. Subsequently, patients seek medical attention and undergo clinical examination by a skilled clinician. The clinical diagnosis is subsequently reviewed by a second experienced clinician. If the diagnoses align, it is considered the gold standard. In cases of discrepancy, the consensus reached by the two clinicians becomes the gold standard.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multimodal Machine Learning Program for Auxiliary Diagnosis of Eye Diseases
Patients presenting with eye-related chief complaints initially complete a mobile phone application. This application utilizes patient medical history and relevant images (such as selfies and photos from eye examinations) to provide intelligent diagnosis. The diagnosis remains undisclosed to the patients. Subsequently, patients seek medical attention and undergo clinical examination by a skilled clinician. The clinical diagnosis is subsequently reviewed by a second experienced clinician. If the diagnoses align, it is considered the gold standard. In cases of discrepancy, the consensus reached by the two clinicians becomes the gold standard.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants should be able to have Chinese as their mother tongue, and be sufficiently able to read, write and understand Chinese;
* For normal participants: individuals should have no concerns related to their eyes.
* For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes.
Exclusion Criteria
* Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.
2 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Eye Hospital of Nanjing Medical University
UNKNOWN
Suqian First Hospital
OTHER
Eye & ENT Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Affiliated Eye Hospital of Nanjing Medical University
Nanjing, , China
Fudan Eye & ENT Hospital
Shanghai, , China
Suqian First People's Hospital
Suqian, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ma R, Cheng Q, Yao J, Peng Z, Yan M, Lu J, Liao J, Tian L, Shu W, Zhang Y, Wang J, Jiang P, Xia W, Li X, Gan L, Zhao Y, Zhu J, Qin B, Jiang Q, Wang X, Lin X, Chen H, Zhu W, Xiang D, Nie B, Wang J, Guo J, Xue K, Cui H, Cheng J, Zhu X, Hong J, Shi F, Zhang R, Chen X, Zhao C. Multimodal machine learning enables AI chatbot to diagnose ophthalmic diseases and provide high-quality medical responses. NPJ Digit Med. 2025 Jan 27;8(1):64. doi: 10.1038/s41746-025-01461-0.
Peng Z, Ma R, Zhang Y, Yan M, Lu J, Cheng Q, Liao J, Zhang Y, Wang J, Zhao Y, Zhu J, Qin B, Jiang Q, Shi F, Qian J, Chen X, Zhao C. Development and evaluation of multimodal AI for diagnosis and triage of ophthalmic diseases using ChatGPT and anterior segment images: protocol for a two-stage cross-sectional study. Front Artif Intell. 2023 Dec 8;6:1323924. doi: 10.3389/frai.2023.1323924. eCollection 2023.
Related Links
Access external resources that provide additional context or updates about the study.
Development and evaluation of multimodal AI for diagnosis and triage of ophthalmic diseases using ChatGPT and anterior segment images: protocol for a two-stage cross-sectional study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FD-EENT-20230625
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.